Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Surgery PartnersSGRY -2.61%66 FCF Yield % is 10.66 as of Aug. 07, 2026, which is 52% above its 10-year median of 7.00. GuruFocus rates SGRY with a GF Score™ of 66/100 and a GF Value™ of $26.81 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 682 Healthcare Providers & Services companies, Surgery Partners ranks better than 84.46% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Surgery Partners FCF Yield % Related Terms
Surgery Partners FCF Yield % Historical Data
* Premium members only.
The historical data trend for Surgery Partners's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Surgery Partners's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Surgery Partners FCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Surgery Partners's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Surgery Partners's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Surgery Partners (SGRY) has a FCF Yield % of 10.66 as of Aug. 07, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Surgery Partners and its competitors. This is 52% above median its historical median of 7.00. Over the past decade, Surgery Partners' FCF Yield % has ranged from 0.41 to 42.43. According to the industry distribution chart, Surgery Partners ranks #106 out of 682 companies in the Healthcare Providers & Services industry, placing it in the top 15.5%.
Is Surgery Partners' FCF Yield % too high?
Surgery Partners' current FCF Yield % of 10.66 is 52% above median its 10-year median of 7.00. Over the past 10 years, this metric has ranged from a low of 0.41 to a high of 42.43. The Healthcare Providers & Services industry median FCF Yield % is 1.83. Surgery Partners' value of 10.66 is 484.1% above this industry median. Based on the distribution chart, Surgery Partners ranks #106 out of 682 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Surgery Partners has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Surgery Partners' FCF Yield % compare to AVAH and ASTH?
According to the Healthcare Providers & Services industry distribution chart, Surgery Partners ranks #106 out of 682 companies for FCF Yield %. This places Surgery Partners in the top 16% of its industry — outperforming the majority of peers. The industry median FCF Yield % is 1.83. Surgery Partners' value of 10.66 is 484.1% above this benchmark. Historically, Surgery Partners' own FCF Yield % has ranged from 0.41 to 42.43 over the past decade. While the company's 10-year median is 7.00 vs. the industry median of 1.83, Surgery Partners has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Healthcare Providers & Services company?
The median FCF Yield % among Healthcare Providers & Services companies is 1.83, based on 682 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Surgery Partners's current FCF Yield % of 10.66 is 484.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Surgery Partners and its competitors. For the Healthcare Providers & Services industry, the median FCF Yield % is 1.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Surgery Partners's current FCF Yield % is 10.66, which is 52% above median its own 10-year median of 7.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgery Partners stock overvalued right now?
Based on GuruFocus' analysis, Surgery Partners (SGRY) is currently considered Possible Value Trap. The stock's GF Value™ is $26.81, compared to a current price of $14.92 — trading 44.3% below its estimated fair value. The current FCF Yield % is 10.66, which is 52% above median its 10-year median of 7.00 and 484.1% above the Healthcare Providers & Services industry median of 1.83. Surgery Partners' overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Surgery Partners (SGRY), the current FCF Yield % is 10.66 as of Aug. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Surgery Partners (SGRY) Overvalued in 2026?
Based on GuruFocus' analysis, Surgery Partners stock appears to be undervalued.
The current stock price of $14.92 is trading 44.3% below its estimated GF Value™ of $26.81.
GuruFocus considers Surgery Partners to be Possible Value Trap.
Key valuation signals for SGRY:
FCF Yield %: 10.66 (52% above median its 10-year median of 7.00)
GF Value™: $26.81 vs. price of $14.92 (44.3% below fair value)
Industry Position: 484.1% above the Healthcare Providers & Services median (#106 of 682)
No single metric tells the full story. See the SGRY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.
66GF Score
Get the complete analysis for SGRY
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGRY has been successfully added to your 
